Identification of STAT5A and STAT5B target genes in human T cells

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Kanai, Takahiro ^a   Seki, Scott ^a   Jenks, Jennifer A ^a   Kohli, Arunima ^a   Kawli, Trupti ^a   Martin, Dorrelyn Patacsil ^a   Snyder, Michael ^a   Bacchetta, Rosa ^a,b   Nadeau, Kari C ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SAN RAFFAELE SCIENTIFIC INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

SERUM AND GLUCOCORTICOID REGULATED KINASE 1; STAT5A PROTEIN; STAT5B PROTEIN; TRANSCRIPTION FACTOR FOXP3; STAT5 PROTEIN; STAT5A PROTEIN, HUMAN; STAT5B PROTEIN, HUMAN; TRANSCRIPTOME; TUMOR SUPPRESSOR PROTEIN;

APOPTOSIS; ARTICLE; CD4+ T LYMPHOCYTE; CELL MATURATION; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DNA SEQUENCE; DNAJC6 GENE; DOCK8 GENE; FOXP3 GENE; GENE; GENE CONTROL; GENE FUNCTION; GENE IDENTIFICATION; GENE INTERACTION; GENE SILENCING; GENE TARGETING; HUMAN; HUMAN CELL; IL2RA GENE; LYMPHOCYTE FUNCTION; NDRG1 GENE; NERVE GROWTH; POLYMERASE CHAIN REACTION; PROTEIN BINDING; QUANTITATIVE ANALYSIS; SGK1 GENE; SNX9 GENE; SSH2 GENE; STAT5A GENE; STAT5B GENE; T LYMPHOCYTE; VALIDATION STUDY; ACTIVE TRANSPORT; BINDING SITE; CELL CULTURE; CONSENSUS SEQUENCE; NUCLEOTIDE SEQUENCE; PHYSIOLOGY; PROTEIN MULTIMERIZATION; TRANSCRIPTION INITIATION;

ACTIVE TRANSPORT, CELL NUCLEUS; BASE SEQUENCE; BINDING SITES; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; CONSENSUS SEQUENCE; HUMANS; PROTEIN MULTIMERIZATION; STAT5 TRANSCRIPTION FACTOR; TRANSCRIPTIONAL ACTIVATION; TRANSCRIPTOME; TUMOR SUPPRESSOR PROTEINS;

EID: 84900453853     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0086790     Document Type: Article

References (55)

1. Lin JX, Leonard WJ (2000) The role of Stat5a and Stat5b in signaling by IL-2 family cytokines. Oncogene 19: 2566-2576.
2. Rochman Y, Spolski R, Leonard WJ (2009) New insights into the regulation of T cells by gamma(c) family cytokines. Nat Rev Immunol 9: 480-490.
3. Leonard WJ, O'Shea JJ (1998) Jaks and STATs: biological implications. Annu Rev Immunol 16: 293-322. (Pubitemid 28183367)
4. Soldaini E, John S, Moro S, Bollenbacher J, Schindler U, et al. (2000) DNA binding site selection of dimeric and tetrameric Stat5 proteins reveals a large repertoire of divergent tetrameric Stat5a binding sites. Mol Cell Biol 20: 389-401. (Pubitemid 30002580)
5. Lin JX, Mietz J, Modi WS, John S, Leonard WJ (1996) Cloning of human Stat5B. Reconstitution of interleukin-2-induced Stat5A and Stat5B DNA binding activity in COS-7 cells. J Biol Chem 271: 10738-10744. (Pubitemid 26145810)
6. Nelson EA, Walker SR, Li W, Liu XS, Frank DA (2006) Identification of human STAT5-dependent gene regulatory elements based on interspecies homology. J Biol Chem 281: 26216-26224. (Pubitemid 44401829)
7. Yao Z, Cui Y, Watford WT, Bream JH, Yamaoka K, et al. (2006) Stat5a/b are essential for normal lymphoid development and differentiation. Proc Natl Acad Sci U S A 103: 1000-1005. (Pubitemid 43212211)
8. Kelly J, Spolski R, Imada K, Bollenbacher J, Lee S, et al. (2003) A role for Stat5 in CD8+ T cell homeostasis. J Immunol 170: 210-217. (Pubitemid 36026142)
9. Liu X, Robinson GW, Wagner KU, Garrett L, Wynshaw-Boris A, et al. (1997) Stat5a is mandatory for adult mammary gland development and lactogenesis. Genes Dev 11: 179-186. (Pubitemid 27081895)
10. Udy GB, Towers RP, Snell RG, Wilkins RJ, Park SH, et al. (1997) Requirement of STAT5b for sexual dimorphism of body growth rates and liver gene expression. Proc Natl Acad Sci U S A 94: 7239-7244. (Pubitemid 27345299)
11. Nadeau K, Hwa V, Rosenfeld RG (2011) STAT5b deficiency: an unsuspected cause of growth failure, immunodeficiency, and severe pulmonary disease. J Pediatr 158: 701-708.
12. Liao W, Schones DE, Oh J, Cui Y, Cui K, et al. (2008) Priming for T helper type 2 differentiation by interleukin 2-mediated induction of interleukin 4 receptor alpha-chain expression. Nat Immunol 9: 1288-1296.
13. Casanova JL, Holland SM, Notarangelo LD (2012) Inborn errors of human JAKs and STATs. Immunity 36: 515-528.
14. Kofoed EM, Hwa V, Little B, Woods KA, Buckway CK, et al. (2003) Growth hormone insensitivity associated with a STAT5b mutation. N Engl J Med 349: 1139-1147. (Pubitemid 37122326)
15. Bernasconi A, Marino R, Ribas A, Rossi J, Ciaccio M, et al. (2006) Characterization of immunodeficiency in a patient with growth hormone insensitivity secondary to a novel STAT5b gene mutation. Pediatrics 118: e1584-1592.
16. Jenks JA, Seki S, Kanai T, Huang J, Morgan AA, et al. (2013) Differentiating the roles of STAT5B and STAT5A in human CD4(+) T cells. Clinical Immunology 148: 227-236.
17. Lu N, Wang YH, Arima K, Hanabuchi S, Liu YJ (2009) TSLP and IL-7 use two different mechanisms to regulate human CD4+ T cell homeostasis. J Exp Med 206: 2111-2119.
18. Euskirchen GM, Rozowsky JS, Wei CL, Lee WH, Zhang ZD, et al. (2007) Mapping of transcription factor binding regions in mammalian cells by ChIP: comparison of array- and sequencing-based technologies. Genome Res 17: 898-909. (Pubitemid 46919724)
19. Grimley PM, Dong F, Rui H (1999) Stat5a and Stat5b: fraternal twins of signal transduction and transcriptional activation. Cytokine Growth Factor Rev 10: 131-157. (Pubitemid 29446377)
20. Laloraya M, Davoodi-Semiromi A, Kumar GP, McDuffie M, She JX (2006) Impaired Crkl expression contributes to the defective DNA binding of Stat5b in nonobese diabetic mice. Diabetes 55: 734-741. (Pubitemid 43343230)
21. Schulze H, Ballmaier M, Welte K, Germeshausen M (2000) Thrombopoietin induces the generation of distinct Stat1, Stat3, Stat5a and Stat5b homo- and heterodimeric complexes with different kinetics in human platelets. Exp Hematol 28: 294-304. (Pubitemid 30137997)
22. Peng B, Sutherland KD, Sum EY, Olayioye M, Wittlin S, et al. (2002) CPAP is a novel stat5-interacting cofactor that augments stat5-mediated transcriptional activity. Mol Endocrinol 16: 2019-2033. (Pubitemid 35013452)
23. Shuai K (2000) Modulation of STAT signaling by STAT-interacting proteins. Oncogene 19: 2638-2644.
24. Zhu BM, Kang K, Yu JH, Chen W, Smith HE, et al. (2012) Genome-wide analyses reveal the extent of opportunistic STAT5 binding that does not yield transcriptional activation of neighboring genes. Nucleic Acids Res 40: 4461-4472.
25. Yamaji D, Kang K, Robinson GW, Hennighausen L (2013) Sequential activation of genetic programs in mouse mammary epithelium during pregnancy depends on STAT5A/B concentration. Nucleic Acids Res 41: 1622-1636.
26. Ferbeyre G, Moriggl R (2011) The role of Stat5 transcription factors as tumor suppressors or oncogenes. Biochim Biophys Acta 1815: 104-114.
27. Abbruzzese C, Mattarocci S, Pizzuti L, Mileo AM, Visca P, et al. (2012) Determination of SGK1 mRNA in non-small cell lung cancer samples underlines high expression in squamous cell carcinomas. J Exp Clin Cancer Res 31: 4.
28. Ronchi CL, Sbiera S, Leich E, Tissier F, Steinhauer S, et al. (2012) Low SGK1 expression in human adrenocortical tumors is associated with ACTHindependent glucocorticoid secretion and poor prognosis. J Clin Endocrinol Metab 97: E2251-2260.
29. Markham K, Schuurmans C, Weiss S (2007) STAT5A/B activity is required in the developing forebrain and spinal cord. Mol Cell Neurosci 35: 272-282. (Pubitemid 46843564)
30. Tran TH, Utama FE, Lin J, Yang N, Sjolund AB, et al. (2010) Prolactin inhibits BCL6 expression in breast cancer through a Stat5a-dependent mechanism. Cancer Res 70: 1711-1721.
31. Pathipati P, Gorba T, Scheepens A, Goffin V, Sun Y, et al. (2011) Growth hormone and prolactin regulate human neural stem cell regenerative activity. Neuroscience 190: 409-427.
32. Randall KL, Chan SS, Ma CS, Fung I, Mei Y, et al. (2011) DOCK8 deficiency impairs CD8 T cell survival and function in humans and mice. J Exp Med 208: 2305-2320.
33. Zhang Q, Davis JC, Lamborn IT, Freeman AF, Jing H, et al. (2009) Combined immunodeficiency associated with DOCK8 mutations. N Engl J Med 361: 2046-2055.
34. Kanai T, Jenks J, Nadeau KC (2012) The STAT5b Pathway Defect and Autoimmunity. Front Immunol 3: 234.
35. Badour K, McGavin MK, Zhang J, Freeman S, Vieira C, et al. (2007) Interaction of the Wiskott-Aldrich syndrome protein with sorting nexin 9 is required for CD28 endocytosis and cosignaling in T cells. Proc Natl Acad Sci U S A 104: 1593-1598. (Pubitemid 46214635)
36. Basham B, Sathe M, Grein J, McClanahan T, D'Andrea A, et al. (2008) In vivo identification of novel STAT5 target genes. Nucleic Acids Res 36: 3802-3818. (Pubitemid 351917541)
37. Pugliese-Pires PN, Tonelli CA, Dora JM, Silva PC, Czepielewski M, et al. (2010) A novel STAT5B mutation causing GH insensitivity syndrome associated with hyperprolactinemia and immune dysfunction in two male siblings. Eur J Endocrinol 163: 349-355.
38. Goudy K, Aydin D, Barzaghi F, Gambineri E, Vignoli M, et al. (2013) Human IL2RA null mutation mediates immunodeficiency with lymphoproliferation and autoimmunity. Clin Immunol 146: 248-261.
39. Lang F, Bohmer C, Palmada M, Seebohm G, Strutz-Seebohm N, et al. (2006) (Patho)physiological significance of the serum- and glucocorticoid-inducible kinase isoforms. Physiol Rev 86: 1151-1178. (Pubitemid 44521650)
40. Giglia-Mari G, Coin F, Ranish JA, Hoogstraten D, Theil A, et al. (2004) A new, tenth subunit of TFIIH is responsible for the DNA repair syndrome trichothiodystrophy group A. Nat Genet 36: 714-719. (Pubitemid 38886632)
41. Nezu J, Tamai I, Oku A, Ohashi R, Yabuuchi H, et al. (1999) Primary systemic carnitine deficiency is caused by mutations in a gene encoding sodium iondependent carnitine transporter. Nat Genet 21: 91-94. (Pubitemid 29036290)
42. Melotte V, Qu X, Ongenaert M, van Criekinge W, de Bruine AP, et al. (2010) The N-myc downstream regulated gene (NDRG) family: diverse functions, multiple applications. FASEB J 24: 4153-4166.
43. Kalaydjieva L, Gresham D, Gooding R, Heather L, Baas F, et al. (2000) N-myc downstream-regulated gene 1 is mutated in hereditary motor and sensory neuropathy-Lom. Am J Hum Genet 67: 47-58. (Pubitemid 30481543)
44. Vauthier V, Jaillard S, Journel H, Dubourg C, Jockers R, et al. (2012) Homozygous deletion of an 80 kb region comprising part of DNAJC6 and LEPR genes on chromosome 1P31.3 is associated with early onset obesity, mental retardation and epilepsy. Mol Genet Metab 106: 345-350.
45. Van Dyken SJ, Green RS, Marth JD (2007) Structural and mechanistic features of protein O glycosylation linked to CD8+ T-cell apoptosis. Mol Cell Biol 27: 1096-1111. (Pubitemid 46174570)
46. Baez MV, Luchelli L, Maschi D, Habif M, Pascual M, et al. (2011) Smaug1 mRNA-silencing foci respond to NMDA and modulate synapse formation. J Cell Biol 195: 1141-1157.
47. Endo M, Ohashi K, Mizuno K (2007) LIM kinase and slingshot are critical for neurite extension. J Biol Chem 282: 13692-13702. (Pubitemid 47100568)
48. Lin FR, Huang SY, Hung KH, Su ST, Chung CH, et al. (2012) ASK1 promotes apoptosis of normal and malignant plasma cells. Blood 120: 1039-1047.
49. Nunez G, Merino R, Grillot D, Gonzalez-Garcia M (1994) Bcl-2 and Bcl-x: regulatory switches for lymphoid death and survival. Immunol Today 15: 582-588. (Pubitemid 24353910)
50. Wang H, Moon EY, Azouz A, Wu X, Smith A, et al. (2003) SKAP-55 regulates integrin adhesion and formation of T cell-APC conjugates. Nat Immunol 4: 366-374. (Pubitemid 36432320)
51. Nomura S, Ishii K, Inami N, Uoshima N, Ishida H, et al. (2007) Role of soluble tumor necrosis factor-related apoptosis-inducing ligand concentrations after stem cell transplantation. Transpl Immunol 18: 115-121. (Pubitemid 350086955)
52. Sakaguchi S, Yamaguchi T, Nomura T, Ono M (2008) Regulatory T cells and immune tolerance. Cell 133: 775-787. (Pubitemid 351707693)
53. Sharfe N, Dadi HK, Shahar M, Roifman CM (1997) Human immune disorder arising from mutation of the alpha chain of the interleukin-2 receptor. Proc Natl Acad Sci U S A 94: 3168-3171. (Pubitemid 27157282)
54. Liu YY, Patwardhan GA, Bhinge K, Gupta V, Gu X, et al. (2011) Suppression of glucosylceramide synthase restores p53-dependent apoptosis in mutant p53 cancer cells. Cancer Res 71: 2276-2285.
55. Messner MC, Cabot MC (2010) Glucosylceramide in humans. Adv Exp Med Biol 688: 156-164.